City

Tianjin (1)

Condition

Essential Thrombocytopenia (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Institute of Hematology & Blood Diseases Hospital (1)

Collaborator

Intervention

pegylated interferon alfa-2b (1)

recombinant interferon alpha (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

essential thrombocytopenia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting

Essential Thrombocytopenia

Recombinant Interferon Alpha
Pegylated interferon alfa-2b

Tianjin, Tianjin, China

Institute of Hematology & Blood Diseases Hospital

Jul 18, 2022